Induction treatment of chronic hepatitis C with daily interferon plus ribavirin plus amantadine is effective in non-responders to interferon plus ribavirin

被引：0
|
作者：
Stauber, R [1 ]
Munda-Steindl, P [1 ]
Hackl, F [1 ]
Schüutze, K [1 ]
Datz, C [1 ]
Hofer, H [1 ]
Hegenbarth, K [1 ]
Jessner, W [1 ]
Ferenci, P [1 ]
机构：
[1] Dept Internal Med, Vienna, Austria
来源：
JOURNAL OF HEPATOLOGY | 2001年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：134 / 135
页数：2
相关论文
共 50 条
  • [41] Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C
    Satsangi, Sandeep
    Mehta, Manu
    Duseja, Ajay
    Taneja, Sunil
    Dhiman, Radha K.
    Chawla, Yogesh
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 859 - 863
  • [42] A preliminary study of ribavirin plus interferon in the treatment for Chronic Hepatitis C.
    Bailey, BJ
    Meyer, DL
    [J]. HEPATOLOGY, 1997, 26 (04) : 1392 - 1392
  • [43] Peginterferon alpha-2b plus ribavirin with or without amantidine for the treatment of non-responders to standard interferon and ribavirin
    Hasan, F
    Al-Khaldi, J
    Asker, H
    Al-Ajmi, M
    Owayed, S
    Varghese, R
    Siddique, L
    Al-Nakib, B
    [J]. ANTIVIRAL THERAPY, 2004, 9 (04) : 499 - 503
  • [44] Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C
    McHutchison, JG
    Poynard, T
    [J]. SEMINARS IN LIVER DISEASE, 1999, 19 : 57 - 65
  • [45] Ribavirin plus alfa-interferon and ribavirin alone in resistant chronic hepatitis C
    Tripi, S
    DiGaetano, G
    Montalto, G
    Soresi, M
    Ortoleva, A
    Migneco, G
    [J]. HEPATOLOGY, 1996, 24 (04) : 1857 - 1857
  • [46] Cyclic and periodic interferon treatment with n.interferon β plus HLBI is effective for non-responders with chronic hepatitis C.
    Kishida, Y
    Naitoh, M
    Katayama, K
    Kashiwagi, T
    Hayashi, N
    Kinoshita, M
    [J]. HEPATOLOGY, 1999, 30 (04) : 617A - 617A
  • [47] Influence of genotype, viral load and fibrosis on the sustained virologic response rate to pegylated interferon alpha-2a plus ribavirin, with or without amantadine, in chronic hepatitis C patients non-responders to alpha interferferon plus ribavirin
    Cheinquer, H.
    Pessoa, M.
    Sette, H., Jr.
    Parise, E.
    Parana, R.
    Tatsch, F.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S147 - S147
  • [48] Interferon plus ribavirin (6 vs 12 months) in chronic hepatitis C patients non responders to interferon alone.
    Picciotto, A
    Torre, F
    Campo, N
    Giusto, R
    Brizzolara, R
    Sinelli, N
    Giudici-Cipriani, A
    Grasso, A
    De Conca, V
    Marenco, G
    Menardo, G
    Michetti, P
    [J]. HEPATOLOGY, 1999, 30 (04) : 263A - 263A
  • [49] Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
    Abbas, Zaigham
    Tayyab, Ghiasun Nabi
    Qureshi, Mustafa
    Memon, Mohammad Sadik
    Subhan, Amna
    Shakir, Tanzila
    Jafri, Wasim
    Hamid, Saeed
    [J]. HEPATITIS MONTHLY, 2013, 13 (12)
  • [50] Amantadine plus interferon is not effective in non responder to interferon chronic hepatitis C patients.
    Diago, M
    Perez-Anton, C
    García, V
    Carbonell, P
    Cors, R
    Aznar, V
    Martinez, M
    Andreu, J
    [J]. HEPATOLOGY, 1999, 30 (04) : 629A - 629A
12345